Astra Zeneca resumes trial of COVID-19 vaccine

Following a voluntary pause on September 6th after one trial volunteer experienced an unexplained illness, the MHRA has now reviewed safety data and authorised that the trial of the AZD1222 COVID-19 vaccine is safe to continue.

PharmaTimes